Literature DB >> 32280103

Angiotensin II Blood Levels Are Associated with Smaller Hippocampal and Cortical Volumes in Cognitively Normal Older Adults.

Sevil Yasar1, Kyle D Moored2, Atif Adam2, Fiona Zabel3, Yi-Fang Chuang4, Vijay R Varma5, Michelle C Carlson2.   

Abstract

BACKGROUND: There is emerging evidence about possible involvement of the renin-angiotensin system (RAS) in the pathogenesis of Alzheimer's disease (AD) and decline of cognitive function. However, little is known about associations with brain biomarkers.
OBJECTIVE: Our study aimed to examine associations between blood ACE-1 and ANG II levels and brain MRI based volumes in non-demented participants, and whether these associations were mediated by blood pressure.
METHODS: This cross-sectional study was conducted in 34 older participants from the Baltimore Experience Corps Trial (BECT) Brain Health Sub-study (BHS). Blood ANGII and ACE-1 levels were measured by ELISA and brain MRI volumes were generated using FreeSurfer 6.0. Multiple linear regression analysis, adjusting for intracranial volume and confounders, was used to determine associations between log transformed ANGII and ACE-1 levels and MRI volumes (mm3).
RESULTS: Participants were predominantly female (76%), African-American (94%), with mean age of 66.9 and education of 14.4 years. In the fully adjusted model we observed significant inverse associations between log ANGII levels and total grey matter (β=Angiotensin II associated with smaller hippocampus14,935.50, ±7,444.83, p = 0.05), total hippocampus (β=-129.97, ±105.27, p = 0.03), rostral middle frontal (β= -1580.40, ±584.74, p = 0.02), and supramarginal parietal (β= -978.90, ±365.54, p = 0.02) volumes. There were no associations between ANGII levels and total white matter or entorhinal cortex volumes, or ACE-1 levels and any brain volumes.
CONCLUSION: We observed that increased blood ANGII levels were associated with lower total grey matter, hippocampal, rostral middle frontal, and supramarginal parietal volumes, which are associated with cognitive domains that decline in preclinical AD.

Entities:  

Keywords:  Angiotensin II; MRI; angiotensin converting enzyme-1; cohort study

Mesh:

Substances:

Year:  2020        PMID: 32280103      PMCID: PMC7293768          DOI: 10.3233/JAD-200118

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  29 in total

1.  Shared and distinct neurophysiological components of the digits forward and backward tasks as revealed by functional neuroimaging.

Authors:  Brooke K Gerton; Timothy T Brown; Andreas Meyer-Lindenberg; Philip Kohn; John L Holt; Rosanna K Olsen; Karen Faith Berman
Journal:  Neuropsychologia       Date:  2004       Impact factor: 3.139

Review 2.  Current status of renin-aldosterone angiotensin system-targeting anti-hypertensive drugs as therapeutic options for Alzheimer's disease.

Authors:  Emma Louise Ashby; Patrick G Kehoe
Journal:  Expert Opin Investig Drugs       Date:  2013-06-26       Impact factor: 6.206

3.  Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers.

Authors:  Clifford R Jack; David S Knopman; William J Jagust; Ronald C Petersen; Michael W Weiner; Paul S Aisen; Leslie M Shaw; Prashanthi Vemuri; Heather J Wiste; Stephen D Weigand; Timothy G Lesnick; Vernon S Pankratz; Michael C Donohue; John Q Trojanowski
Journal:  Lancet Neurol       Date:  2013-02       Impact factor: 44.182

4.  Associations of Angiotensin Converting Enzyme-1 and Angiotensin II Blood Levels and Cognitive Function.

Authors:  Sevil Yasar; Vijay R Varma; Gregory C Harris; Michelle C Carlson
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 5.  The age-dependent relation of blood pressure to cognitive function and dementia.

Authors:  Chengxuan Qiu; Bengt Winblad; Laura Fratiglioni
Journal:  Lancet Neurol       Date:  2005-08       Impact factor: 44.182

6.  Angiotensin-converting enzyme levels and activity in Alzheimer's disease: differences in brain and CSF ACE and association with ACE1 genotypes.

Authors:  Scott Miners; Emma Ashby; Shabnam Baig; Rachel Harrison; Hannah Tayler; Elizabeth Speedy; Jonathan A Prince; Seth Love; Patrick G Kehoe
Journal:  Am J Transl Res       Date:  2009-01-18       Impact factor: 4.060

Review 7.  Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors.

Authors:  Albert Fournier; Roxana Oprisiu-Fournier; Jean-Marie Serot; Olivier Godefroy; Jean-Michel Achard; Sebastien Faure; Hakim Mazouz; Mohamed Temmar; Adriana Albu; Régis Bordet; Olivier Hanon; François Gueyffier; Jiguang Wang; Sandra Black; Naoyuki Sato
Journal:  Expert Rev Neurother       Date:  2009-09       Impact factor: 4.618

Review 8.  Do angiotensin receptor blockers prevent Alzheimer's disease?

Authors:  Ihab Hajjar; Kathleen Rodgers
Journal:  Curr Opin Cardiol       Date:  2013-07       Impact factor: 2.161

Review 9.  Angiotensins in Alzheimer's disease - friend or foe?

Authors:  Patrick G Kehoe; Scott Miners; Seth Love
Journal:  Trends Neurosci       Date:  2009-09-30       Impact factor: 13.837

10.  Experience Corps: a dual trial to promote the health of older adults and children's academic success.

Authors:  Linda P Fried; Michelle C Carlson; Sylvia McGill; Teresa Seeman; Qian-Li Xue; Kevin Frick; Erwin Tan; Elizabeth K Tanner; Jeremy Barron; Constantine Frangakis; Rachel Piferi; Iveris Martinez; Tara Gruenewald; Barbara K Martin; Laprisha Berry-Vaughn; John Stewart; Kay Dickersin; Paul R Willging; George W Rebok
Journal:  Contemp Clin Trials       Date:  2013-05-13       Impact factor: 2.226

View more
  5 in total

1.  Losartan Mitigates Oxidative Stress in the Brains of Aged and Inflamed IL-10-/- Mice.

Authors:  Nazaneen Saleh; Caglar Cosarderelioglu; Ramya Vajapey; Jeremy Walston; Peter M Abadir
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2022-09-01       Impact factor: 6.591

2.  Circulating Angiotensin-(1-7) Is Reduced in Alzheimer's Disease Patients and Correlates With White Matter Abnormalities: Results From a Pilot Study.

Authors:  Victor Teatini Ribeiro; Thiago Macedo E Cordeiro; Roberta da Silva Filha; Lucas Giandoni Perez; Paulo Caramelli; Antônio Lúcio Teixeira; Leonardo Cruz de Souza; Ana Cristina Simões E Silva
Journal:  Front Neurosci       Date:  2021-04-06       Impact factor: 4.677

Review 3.  Multiple Aspects of Inappropriate Action of Renin-Angiotensin, Vasopressin, and Oxytocin Systems in Neuropsychiatric and Neurodegenerative Diseases.

Authors:  Ewa Szczepanska-Sadowska; Agnieszka Wsol; Agnieszka Cudnoch-Jedrzejewska; Katarzyna Czarzasta; Tymoteusz Żera
Journal:  J Clin Med       Date:  2022-02-09       Impact factor: 4.241

Review 4.  Brain Renin-Angiotensin System at the Intersect of Physical and Cognitive Frailty.

Authors:  Caglar Cosarderelioglu; Lolita S Nidadavolu; Claudene J George; Esther S Oh; David A Bennett; Jeremy D Walston; Peter M Abadir
Journal:  Front Neurosci       Date:  2020-09-30       Impact factor: 4.677

5.  Diagnosing sarcopenia: Functional perspectives and a new algorithm from the ISarcoPRM.

Authors:  Murat Kara; Bayram Kaymak; Walter Frontera; Ayşe Merve Ata; Vincenzo Ricci; Timur Ekiz; Ke-Vin Chang; Der-Sheng Han; Xanthi Michail; Michael Quittan; Jae-Young Lim; Jonathan F Bean; Franco Franchignoni; Levent Özçakar
Journal:  J Rehabil Med       Date:  2021-06-21       Impact factor: 2.912

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.